• Founder & CEO · Genefitletics
    Sushant
    Kumar
    Solving the impossible with technology & innovation

    Over a 22-year career, Sushant Kumar has served as a strategic architect of organic and inorganic growth for industry leaders and emerging startups alike. Operating at the intersection of enterprise strategy, corporate finance, and disruptive innovation across healthcare, automotive, farm equipment, and media, he has driven multimillion-dollar revenue expansion and global scale. His track record includes executing high-stakes M&A deals, leading corporate restructurings, and founding two joint venture asset finance enterprises.Today, he leverages his multi-sector multi functional background to build and scale next-generation ventures that transform human health.

    22yr
    Corporate Career
    35Bn
    Molecular Datasets
    Sushant Kumar — Founder & CEO, Genefitletics
    Sushant Kumar
    Founder & CEO · Genefitletics · New Delhi, India
    22+
    Years Leadership Experience
    2×
    Serial Entrepreneur
    3
    Books & Publications Authored
    6+
    Global Industry Awards
    The Story

    From Corporate Strategy to
    Deep-Tech Frontier.

    Sushant Kumar is a finance and strategy veteran, biotech entrepreneur, inventor, and serial venture builder with over 2 decades of cross-sector leadership spanning biotechnology, financial services, agritech, media, and automotive.

    Throughout his career across both global conglomerates and agile startups, Sushant has thrived at the intersection of complexity and ambiguity. A tenacious business transformation leader, he looks beyond current market and technology landscapes to design disruptive solutions that unite economic value with profound social impact.

    “I was born in a traditional environment where you’re tutored to play safe. But when you’ve lost people to diseases that could have been caught earlier, playing safe is no longer an option.”

    Translating overarching strategy into decisive execution, he has spearheaded growth transformations, built scalable commercial models, and generated multi-million-dollar topline and bottomline expansion across the business value chain.

    His multi-industry journey spans the complete business lifecycle—from large-scale manufacturing, farm mechanization, and fintech innovation to e-commerce expansion and deep-tech leadership. Across these diverse domains, he has built an exceptional track record in product innovation, inorganic growth, risk capital raising, mezzanine debt financing, corporate acquisitions, divestitures, and joint ventures.

    The Pivot: Rewriting Preventive Health

    Despite a career built on strategic and financial precision, a personal struggle faced by close family members served as a pivotal turning point. Driven by a growing conviction that modern medicine too often manages chronic symptoms while ignoring their biological root causes, Sushant embarked on a mission to rewrite the preventive health narrative.

    Diving deeply into developmental biology, biophysics, and emerging technologies, Sushant pioneered, developed, and commercialized the industry’s first biophysics and machine learning platform. This patent-pending technology decodes complex biological signals to detect hard-to-identify degenerative diseases and cancer at their earliest stages—effectively bridging clinical precision with commercial strategy to redefine how chronic disease is identified, prevented, and managed.

    Driving Next-Generation Growth

    Working at the nexus of biophysics, business strategy, and data intelligence, Sushant continues to scale disruptive frameworks that transform human health and commercial ecosystems.

    Career Timeline
    🔬
    2019 – present
    Co-Founded Genefitletics
    Founded Genefitletics to prevent & resolve degenerative disease and cancer. Incubated at IIM Udaipur. Raised pre-seed at USD 1 Mn valuation from angel investors.
    📚
    2020-Present
    Inventor
    Invented India’s first & only early detection algorithm for degenerative disease & oral cancer. Currently patent pending in India.
    💼
    2000–2019
    Corporate Finance, M&A & Strategy
    Two decades of leadership spanning corporate finance, investment banking, strategy, and corporate development across biotech, healthcare, automotive, farm mechanization, financial services, and media. Proven track record of raising risk capital, mezzanine debt, and consortium financing, alongside structuring complex M&A and forging joint venture transactions. Pioneer of the farm equipment sector’s first $20M off-balance-sheet financing transaction involving a consortium of over 30 banks and financial institutions
    📚
    2017–2020
    Author
    Published three health focused books — Know Your Body, Your Unique Microbiome: GPS for Better Health & Longevity, and Biohack Your Fitness
    🎓
    2013
    MBA — IE Business School, Madrid
    Distinguished Alumni from one of world’s top-ranked business schools, specialising in corporate finance, strategy and innovation. The IE network opened global perspectives on business model design that would later shape Genefitletics.
    🏆
    2021–2025
    Global Awards & Recognition
    Named Most Impactful Leader in Pharma & BioTech 2021. Awarded by Global Health & Pharma, CorporateLiveWire and BioStartUps (Best Healthtech Startup 2025). Featured in ET Healthworld, BioSpectrum, Express Healthcare and NutraIngredients Asia.
    By the Numbers

    Impact Metrics

    $900 Mn+
    Loan Portfolio Managed
    37.8%
    Strategic Cost Savings
    3X
    Revenue Growth
    Over a 5-year period
    10,000
    Lives Impacted
    Early disease diagnostics impact
    2 JV
    Finance Companies
    Setup & capitalisation
    Product Innovation that is transforming preventive healthcare in India

    A unique and diverse intersection of Biophysics, technology & Business

    🧬
    Biophysics & Systems Biology
    Subject matter expert in mitochondrial biology, microbiome science and the mathematics that is driving future of early disease diagnostics.
    💡
    Product Innovation
    Inventor of Machine Learning models for early detection of Metabolic diseases, IBD, Gum Disease, Oral Cancer & Cellular age.
    📊
    Strategy Leader
    Two decades of raising debt & equity on numerous occasions, successfully closing mezzanine debt, project finance, M& A transactions and setting up 2 joint venture asset finance companies.
    🤝
    B2B Platform Licensing & Partnerships
    Leading commercial strategy for licensing early detection platforms and expanding the geographical footprint of the platform to Singapore & Philippines market.
    🤝
    Corporate finance expert
    20+ years of experience in constructing & negotiating complex financial models and commercial transactions across healthcare & hospital, automotive, farm equipment, media & entertainment, financial services and e-commerce sectors.
    🎙️
    Science Communication & Thought Leadership
    Host of the Genefitletics Health Podcast. Regular commentator in ET Healthworld, BioSpectrum India and NutraIngredients Asia. Published author of three health science books.
    Sushant Kumar receiving Best Healthtech Startup of the Year 2025 at BioStartUps Founders Investors Forum
    🏆 Best Healthtech Startup · 2025

    Recognised at the highest level.

    At the second edition of the BioStartUps Founders Investors Forum 2025 — India’s premier biotech investor-startup convergence platform — Genefitletics was awarded Best Healthtech Startup of the Year. The award reflects the collective vision, science and relentless execution that Sushant has led since founding the company.

    🥇
    BioStartUps FiF 2025 — Best Healthtech Startup of the Year
    🌐
    Global Health & Pharma — Chronic Illness Prevention R&D Biotech Company of the Year, Asia
    🏅
    Acquisition International — Specialist Biotech Company of the Year (Global Excellence)
    🔬
    Silicon India — 10 Most Promising Life Science Startups, 2021
    ⭐
    The Business Fame — 2021’s Most Impactful Leaders in Pharma & BioTech
    🎓
    BCES Vidya Utsav 4.0 — Outstanding Alumni Award (Medical Research), BBPS Brij Vihar · Feb 7, 2026
    Sushant Kumar receiving Outstanding Alumni Award at BCES Vidya Utsav 4.0, BBPS Brij Vihar, Feb 2026
    🎓 Outstanding Alumni · Feb 7, 2026

    Bal Bharati Icon Alumni Award — Medical Research

    Awarded the Outstanding Alumni Award in Medical Research at BCES Vidya Utsav 4.0 — held at BBPS Brij Vihar on 7 February 2026. The award recognises Sushant Kumar (Batch of 1998) as the inventor of India’s first and only bioenergetics + mathematics platform that detects and resolves hard-to-identify metabolic diseases and cancer, and for his recognition as Biotech CEO of the Year 2024 and Most Visionary Autoimmunity Research CEO 2023 in India.

    2024
    Biotech CEO of the Year
    2023
    Most Visionary Autoimmunity Research CEO
    “
    Attitude, competence, and execution are three core pillars in conquering the world and bringing positive change in the lives of people. If you have these three, the sky’s the limit.
    Sushant Kumar · Founder & CEO, Genefitletics · IE Business School Alumni
    Sushant Kumar

    Connect with Sushant.

    Having navigated the full arc of building, funding, and scaling ventures, Sushant collaborates with growth-stage startups, boards, and enterprise leaders in retainer/advisory capacity across areas of engagement encompassing:

    • Board & Strategic Advisory Roles
    • Growth & Go-To-Market (GTM) Strategy
    • Data Intelligence & Deep-Tech Product Development
    • M&A & Corporate Finance
    • Financial modelling for fund raising